期刊文献+

线粒体相关microRNA在非酒精性脂肪性肝病中的研究进展

Research progress of mitochondria-related microRNA in non-alcoholic fatty liver disease
原文传递
导出
摘要 线粒体功能障碍可导致肝脏胰岛素抵抗、脂肪改变及氧化应激等,从而参与非酒精性脂肪性肝病(NAFLD)的发病.近年来研究发现,microRNA(miRNA)可调控多种生物功能,与包括NAFLD在内的多种疾病有关,而其中的线粒体相关miRNA可能通过调控细胞因子、脂肪酸氧化、线粒体复合物、氧化应激等,导致线粒体功能障碍,从而参与NAFLD的发生、发展.目前尚无针对NAFLD的有效治疗,线粒体相关miRNA与NAFLD的研究表明其可能为NAFLD的诊断、治疗提供一个新的方向. Mitochondrial dysfunction is involved in the pathogenesis of non-alcoholic fatty liver dis-ease ( NAFLD) by causing insulin resistance, fat changes and oxidative stress in the liver. Recent studies have shown that microRNA ( miRNA) can regulate a variety of biological functions and is related to a variety of diseases including NAFLD, which is caused by mitochondria-related miRNA through regulation of cyto-kines, fatty acid oxidation, mitochondrial complex and oxidative stress. Until now, no therapeutic treatments have proven effective for the treatment of NAFLD. However,the studies of mitochondria-related miRNA in NAFLD suggest that it may provide a new direction for the diagnosis and treatment of NAFLD.
作者 马卓奇 敖娜 都健 Ma Zhuoqi;Ao Na;Du Jian(Department of Endocrinology and Metabolism,The Fourth Affiliated Hospital of China Medical University,Shenyang 110032,China)
出处 《国际内分泌代谢杂志》 2019年第5期307-310,314,共5页 International Journal of Endocrinology and Metabolism
基金 辽宁省高等学校基本科研项目(LQNK201715).
关键词 非酒精性脂肪性肝病 线粒体 线粒体相关miRNA Non-alcoholic fatty liver disease Mitochondria Mitochondria-related miRNA
  • 相关文献

参考文献2

二级参考文献60

  • 1[1]Clark JM,Brancati FL,Diehl AM.Nonalcoholic fatty liver disease.Gastroenterology 2002; 122:1649-1657
  • 2[2]Franzese A,Vajro P,Argenziano A,Puzziello A,Iannucci MP,Saviano MC,Brunetti F,Rubino A.Liver involvement in obese children.Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population.Dig Dis Sci 1997; 42:1428-1432
  • 3[3]Tominaga K,Kurata JH,Chen YK,Fujimoto E,Miyagawa S,Abe 1,Kusano Y.Prevalence of fatty liver in Japanese children and relationship to obesity.An epidemiological ultrasonographic survey.Dig Dis Sci 1995; 40:2002-2009
  • 4[4]Browning JD,Szczepaniak LS,Dobbins R,Nuremberg P,Horton JD,Cohen JC,Grundy SM,Hobbs HH.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity.Hepatology 2004; 40:1387-1395
  • 5[5]Neuschwander-Tetri BA.Nonalcoholic steatohepatitis and the metabolic syndrome.Am J Med Sci 2005; 330:326-335
  • 6[6]Adams LA,Lymp JF,St Sauver J,Sanderson SO,Lindor KD,Feldstein A,Angulo P.The natural history of nonalcoholic fatty liver disease:a population-based cohort study.Gastroenterology 2005; 129:113-121
  • 7[7]Browning JD,Horton JD.Molecular mediators of hepatic steatosis and liver injury.J Clin Invest 2004; 114:147-152
  • 8[8]Machado M,Cortez-Pinto H.Non-alcoholic steatohepatitis and metabolic syndrome.Curr Opin Clin Nutr Metab Care 2006; 9:637-642
  • 9[9]Seppala-Lindroos A,Vehkavaara S,Hakkinen AM,Goto T,Westerbacka J,Sovijarvi A,Halavaara J,Yki-Jarvinen H.Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.J Clin Endocrinol Metab 2002; 87:3023-3028
  • 10[10]Loria P,Lonardo A,Carulli N.Should nonalcoholic fatty liver disease be renamed? Dig Dis 2005; 23:72-82

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部